Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery

被引:125
作者
Kipper, MJ
Shen, E
Determan, A
Narasimhan, B
机构
[1] Iowa State Univ, Dept Chem Engn, Ames, IA 50011 USA
[2] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA
关键词
polyanhydrides; microspheres; drug delivery; controlled release;
D O I
10.1016/S0142-9612(02)00181-3
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The fabrication, morphological characterization, and drug release kinetics from microspheres of three bioerodible polyanhydrides, poly[1,6-bis(p-carboxyphenoxy)hexane] (poly(CPH)), poly(sebacic anhydride) (poly(SA)), and the copolymer poly(CPH-co-SA) 50:50 (CPH:SA 50:50) is reported. The fabrication technique yields microspheres with different morphologies for each of the three polymers studied, ranging from very smooth exterior surfaces for poly(CPH) to coarse surface roughness with large pores for poly(SA). Release profiles for the model drug, p-nitroaniline are also different for each polymer. The release profile from poly(CPH) has a large initial burst and shows little additional release after 2 days. The release from poly(SA) is nearly zero-order and lasts for about 8 days. The release profile from CPH:SA 50:50 shows a relatively small burst and then exhibits zero-order release for about I month. The different release profiles are attributed to both polymer erosion rates and drug distribution characteristics of the microspheres. Tailored release profiles of a burst followed by zero-order release are obtained by appropriately combining the microspheres. This technique enables independent modulation of both the burst and the zero-order release rate by varying the number of poly(CPH) and poly(SA) microspheres respectively. Additionally, the zero-order release can be extended from about a week to a month by including CPH:SA 50:50 microspheres. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:4405 / 4412
页数:8
相关论文
共 23 条
[1]   Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions [J].
Berkland, C ;
Kim, KK ;
Pack, DW .
JOURNAL OF CONTROLLED RELEASE, 2001, 73 (01) :59-74
[2]  
BRUNNER A, 1996, MICROPARTICULATE SYS, P169
[3]   Prevention of structural perturbations and aggregation upon encapsulation of bovine serum albumin into poly(lactide-co-glycolide) microspheres using the solid-in-oil-in-water technique [J].
Castellanos, IJ ;
Cuadrado, WL ;
Griebenow, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (08) :1099-1107
[4]   Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co-imide) microspheres [J].
Chiba, M ;
Hanes, J ;
Langer, R .
BIOMATERIALS, 1997, 18 (13) :893-901
[5]  
Conix, 1966, MACROMOL SYNTHESES, V2, P95
[6]   POLYANHYDRIDES .1. PREPARATION OF HIGH-MOLECULAR-WEIGHT POLYANHYDRIDES [J].
DOMB, AJ ;
LANGER, R .
JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY, 1987, 25 (12) :3373-3386
[7]  
Goepferich Achim, 1996, Biomaterials, V17, P103
[8]   NEW METHODS OF DRUG DELIVERY [J].
LANGER, R .
SCIENCE, 1990, 249 (4976) :1527-1533
[9]   BIOERODIBLE POLYANHYDRIDES AS DRUG-CARRIER MATRICES .2. BIOCOMPATIBILITY AND CHEMICAL-REACTIVITY [J].
LEONG, KW ;
DAMORE, P ;
MARLETTA, M ;
LANGER, R .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1986, 20 (01) :51-64
[10]  
LEONG KW, 1985, J BIOMED MATER RES, V19, P941, DOI 10.1002/jbm.820190806